We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
+19.89%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$154M
AUM Growth
+$13.1M
(+9.3%)
Cap. Flow
-$2.96M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
74.28%
Holding
99
New
24
Increased
9
Reduced
19
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$3.25M |
| 2 |
Everest Group
EG
|
+$2.23M |
| 3 |
CMA
Comerica
CMA
|
+$2.04M |
| 4 |
Eastman Chemical
EMN
|
+$1.26M |
| 5 |
MetLife
MET
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$4.46M |
| 2 |
Capital One
COF
|
+$2.38M |
| 3 |
Philip Morris
PM
|
+$1.9M |
| 4 |
Public Service Enterprise Group
PEG
|
+$1.82M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.61% |
| 2 | Financials | 13.2% |
| 3 | Consumer Staples | 4.24% |
| 4 | Industrials | 4.18% |
| 5 | Consumer Discretionary | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $54.6M | 35.55% |
595,781
-48,699
| -8% | -$4.46M |
|
|
2
Axsome Therapeutics
AXSM
$12.4B
| $33.5M | 21.84% |
1,302,346
+161,952
| +14% | +$3.25M |
|
|
3
Capital One
COF
$124B
| $10.5M | 6.87% |
116,176
-26,634
| -19% | -$2.38M |
|
4
Kura Oncology
KURA
$922M
| $5.25M | 3.42% |
266,527
+27,611
| +12% | +$458K |
|
|
5
Everest Group
EG
$15.2B
| $2.3M | 1.5% |
+9,312
| New | +$2.23M |
|
|
CMA
6
DELISTED
Comerica
CMA
| $1.99M | 1.3% |
+27,433
| New | +$2.04M |
|
7
Catheter Precision
VTAK
$948K
| $1.9M | 1.24% |
2
+1
| +100% | +$911K |
|
8
Duke Energy
DUK
$102B
| $1.41M | 0.92% |
15,931
+10,931
| +219% | +$966K |
|
|
9
Eastman Chemical
EMN
$7.8B
| $1.29M | 0.84% |
+16,543
| New | +$1.26M |
|
10
General Motors
GM
$74.7B
| $1.25M | 0.82% |
32,518
+26,518
| +442% | +$994K |
|
|
11
MetLife
MET
$61B
| $1.15M | 0.75% |
+23,111
| New | +$1.09M |
|
12
Alaska Air
ALK
$5.15B
| $1.12M | 0.73% |
+17,530
| New | +$1.07M |
|
13
Omnicom Group
OMC
$22.7B
| $1.1M | 0.72% |
+13,478
| New | +$1.06M |
|
14
KB Financial Group
KB
$41.2B
| $1.09M | 0.71% |
+27,727
| New | +$1.08M |
|
|
FITB
15
Fifth Third Bancorp
FITB
$52B
| $1.09M | 0.71% |
+39,008
| New | +$1.07M |
|
16
Welltower
WELL
$178B
| $1.03M | 0.67% |
+12,678
| New | +$997K |
|
17
Healthpeak Properties
DOC
$15.4B
| $1M | 0.65% |
+31,432
| New | +$977K |
|
18
Newell Brands
NWL
$2.16B
| $989K | 0.64% |
+64,133
| New | +$960K |
|
|
IPG
19
DELISTED
Interpublic Group of Companies
IPG
| $987K | 0.64% |
+43,686
| New | +$971K |
|
|
CDTX
20
DELISTED
Cidara Therapeutics
CDTX
| $948K | 0.62% |
28,216
| – | – |
|
|
NLSN
21
DELISTED
Nielsen Holdings plc
NLSN
| $939K | 0.61% |
+41,562
| New | +$1M |
|
22
Kraft Heinz
KHC
$30.4B
| $931K | 0.61% |
+29,985
| New | +$945K |
|
23
CenterPoint Energy
CNP
$29.1B
| $917K | 0.6% |
+32,044
| New | +$955K |
|
24
Iron Mountain
IRM
$38.2B
| $868K | 0.57% |
+27,743
| New | +$909K |
|
25
Kroger
KR
$34.8B
| $868K | 0.57% |
+39,991
| New | +$973K |
|
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Alethea Capital Management held 99 positions worth $154M, up 9.3% from $140M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Alethea Capital Management's Q2 2019 filing shows 24 new, 9 increased, 19 reduced and 18 closed positions. Its largest new stake was Everest Group: 9,312 shares worth $2.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $4.46M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Staples.
- Alethea Capital Management's largest Q2 2019 buy was Everest Group: 9,312 shares worth $2.3M.
- Alethea Capital Management added most to Axsome Therapeutics in Q2 2019, an estimated $3.25M increase.
- Alethea Capital Management's biggest Q2 2019 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $4.46M.
- Alethea Capital Management fully exited Walgreens Boots Alliance in Q2 2019, selling an estimated $1.42M.
- Alethea Capital Management's ten largest holdings make up 74% of its $154M portfolio in Q2 2019.
- Alethea Capital Management opened 24 new positions and closed 18 in Q2 2019.
- Alethea Capital Management's portfolio value rose 9.3% quarter-over-quarter to $154M.
Based on Alethea Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.